{"directed": true, "multigraph": true, "graph": {"pybel_version": "0.13.1-dev", "document_metadata": {"name": "Myeloperoxidase subgraph", "version": "5.1.2", "copyright": "Copyright Â© 2019 Fraunhofer SCAI, All rights reserved.", "licenses": "CC BY 4.0", "contact": "daniel.domingo.fernandez@scai.fraunhofer.de"}, "namespace_url": {"CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/chebi-names.belns", "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns", "GFAM": "https://raw.githubusercontent.com/pharmacome/terminology/3f89d31906739fce9678d868b6a599a851aa7c00/external/hgnc.genefamily-names.belns", "GO": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/go.belns", "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/570376e4c233483b667eab12a1f964950368282a/export/hbp-names.belns", "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/hgnc-symbols.belns", "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh.belns", "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns", "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns", "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns", "GOBP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process/go-biological-process-20170725.belns", "GOCC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-cellular-component/go-cellular-component-20170725.belns", "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns", "MESHC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-chemicals/mesh-chemicals-20170725.belns", "MESHCS": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-cell-structures/mesh-cell-structures-20170511.belns", "MESHD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-diseases/mesh-diseases-20170725.belns", "MESHPP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-processes/mesh-processes-20170725.belns", "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns", "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns", "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns", "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns", "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns", "ADO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/alzheimer-disease-ontology/alzheimer-disease-ontology-1.0.2.belns", "BRCO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/brain-region-ontology/brain-region-ontology-1.0.0.belns", "NIFT": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/imaging-ontology/imaging-ontology-1.0.6.belns", "PTS": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/neurodegeneration-pathways/neurodegeneration-pathways-1.0.0.belns"}, "namespace_pattern": {"DBSNP": "^rs\\d+$", "TAXONOMY": "^\\d+$"}, "namespaces_uncached": [], "annotation_url": {"Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno", "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno", "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno", "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno", "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno", "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno", "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno", "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno", "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno", "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno", "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"}, "annotation_pattern": {"Species": "\\d+"}, "annotation_list": {"Duration_of_Chemical_Exposure": ["Chronic", "Subchronic"], "NIFT": ["Positron Emission Tomography", "Volumetric MRI"], "Published": ["CDR story", "Epilepsy comorbidity paper"], "Race": ["Caucasian", "Chinese", "Colombian", "Italian", "Swedish", "Taiwanese"], "Condition": ["Normal Healthy State"], "Encode_Feature_Types": ["Promoter"], "Experimental_Group": ["Physical exercised group", "Sedentary group"], "KnockoutMice": ["App transgenic"], "DiseaseState": ["Early-onset AD", "Familial Alzheimers Disease", "Late-onset AD", "Mild AD", "Moderate AD", "Sporadic Alzheimers Disease"], "FDASTATUS": ["Phase 2", "Phase 3"], "UserdefinedCellLine": ["293APPwt", "App transgenic", "CHOAPPsw", "INS-1 cells", "N2a695 cell", "NT2N cells", "Neuroblastoma cell", "primary cortical neuron", "primary neuron"], "Patient": ["AD T2DM +ve", "AD T2DM -ve", "APOE e4 +ve", "APOE e4 -ve"], "Developmental_Phase__of_patient": ["Developmental stage", "Old"], "Transcriptionally_active_region": ["3 prime UTR", "5 prime UTR"]}}, "nodes": [{"function": "Abundance", "namespace": "CHEBI", "name": "reactive oxygen species", "id": "5da7879846ec42231f9176e97a7f14c4b573807576fa75be6e3acb71f391f25971e33d2f7fb886003ebd8020ab592e1424e2fc106f91213d546078dd09fabb65"}, {"function": "Abundance", "namespace": "CHEBI", "name": "rivastigmine", "id": "317d5b18448e148088204c7a7dce78316c0ea8b56c70a7adaffe344826b17688e05873b2746050d29c18ae658658e81a2d775ba56b6f5abf8821f4eaca725064"}, {"function": "BiologicalProcess", "namespace": "MESHPP", "name": "Oxidative Stress", "id": "2e38d6f16f5bdfbc33da58532c5bdd2a6e47cde3f52748b83013a33fc1a076ae93e2852e3d3559e7e4b130cae695a61f746fe7fd8b5929ac3761040a5474b31a"}, {"function": "Protein", "namespace": "HGNC", "name": "MPO", "id": "0762f044ed61acb532ae1ad7b1673070817dc18472cfad290b7937e38d89f80dab87b608f8cd9eefe9b7164b9b9e6ee30a35d08b7c1544f5994f9ad45ec8d402"}, {"function": "Protein", "namespace": "HGNC", "name": "TNF", "id": "a262f5edbfb734dd0ec9696a3b78644fccfb4054a9cf9225beb17c33ef416a75809ff59ec1646e29a3cccc804c9294f8d2c48120af9f5ee98e764a584626426d"}, {"function": "Pathology", "namespace": "MESHD", "name": "Alzheimer Disease", "id": "0893d59040331bc1b155187396067458820ab2635e0138b840323082d33d44b964ab1240f5aeb64c5360e1340de40545835bc744c181abb910d64c923d55ff2b"}, {"function": "Pathology", "namespace": "MESHD", "name": "Memory Disorders", "id": "0cbb610a1bcc9d196deaf0f0fde8a66246df7a9d8d0acf9dff087a2ea4091655569db9bb9cab81b8d3bdd7fd03da7e15c506413994444aad40a39a1459bfd1f7"}, {"function": "Pathology", "namespace": "MESHD", "name": "Neurodegenerative Diseases", "id": "1c2038b10ea01bf8107d6a7f89c6faed802bf26e9e9bdb8875fc80950d2d9ceeff1d46923c65422edf5ae29d20d9891cd028013d6784041a8b997da53042c256"}, {"function": "Pathology", "namespace": "MESHD", "name": "Inflammation", "id": "105f4167508b4d96d8df8e04cfb3d84bd7d3af8b312f852502dede706fbd61636cfba0f29d669053a109275f0761f212596ee9f18453d168da563f716b9eaa15"}], "links": [{"line": 21251, "relation": "increases", "evidence": "Neuronal expression of myeloperoxidase is increased in Alzheimer's disease.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"Disease": {"Alzheimer's disease": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 5, "target": 3, "key": "21bc2c79086f4fd39eb9d7a1070ce8f90ed2d68f9209f069fe341a5ce2f8b551deadb923965983e530ce9d1a192e6b49ddce3507eb75339c7c18ea5632e2fd78"}, {"line": 21252, "relation": "positiveCorrelation", "evidence": "Neuronal expression of myeloperoxidase is increased in Alzheimer's disease.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"Disease": {"Alzheimer's disease": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 5, "target": 3, "key": "696d77a36b754a7a5d4092fc94047a7ceba8711b848b64920fe90fc2bec8f9de16ce23f1975c3297132022fba06ce14c20484b07d2b424a3a5a63cbb4d3065db"}, {"line": 23366, "relation": "increases", "evidence": "Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.", "citation": {"type": "PubMed", "reference": "24217274"}, "annotations": {"Species": {"9606": true}, "Disease": {"Alzheimer's disease": true}, "MeSHAnatomy": {"Plasma": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 5, "target": 3, "key": "e41be27de0fe5566b658dae2b8e54132e26e593a8b629c9e54b1b84e9d302eec71a1a3ee52570b591ab46234951528ea957f5416e98f05cec3858729d8959c65"}, {"line": 23439, "relation": "increases", "evidence": "MPO is similarly expressed in astrocytes in human AD tissue.", "citation": {"type": "PubMed", "reference": "19059911"}, "annotations": {"Species": {"9606": true}, "Disease": {"Alzheimer's disease": true}, "MeSHAnatomy": {"Astrocytes": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 5, "target": 3, "key": "51c447072a53af572d412da795c5eb82fbc82383a15d31197615087b443c70a02b0e230168f6709732df6d0baad5e0de208f48202d2b4aa15cbff689e862438a"}, {"line": 23567, "relation": "association", "evidence": "In females, we found a significant association between MPO genotype and AD (P=0.034),", "citation": {"type": "PubMed", "reference": "12946561"}, "annotations": {"Disease": {"Alzheimer's disease": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 5, "target": 3, "key": "1028fe3ee780904e45d7fddcdf816030aa0602a6e19c6f95b522c80c48bc504730d953e025bb5d8303c942b93371acdf55f1655fef2a5fa4981d2f0c85a571bd"}, {"line": 21252, "relation": "positiveCorrelation", "evidence": "Neuronal expression of myeloperoxidase is increased in Alzheimer's disease.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"Disease": {"Alzheimer's disease": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 3, "target": 5, "key": "cb3f1db41856e9f8538e141fa11ab2200094442021254f74b644c27b79dd967dcaeb99a4b913fdee761457df6b97f19e6b6d3a0339da8d825be12eba0c0753da"}, {"line": 23567, "relation": "association", "evidence": "In females, we found a significant association between MPO genotype and AD (P=0.034),", "citation": {"type": "PubMed", "reference": "12946561"}, "annotations": {"Disease": {"Alzheimer's disease": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 3, "target": 5, "key": "890b81aa522c0aa76b69e20084a64e5fbe3e62d66aa99d0a66b43c355e4504842599e1a708e7f10f57de9e9b44c07e8ceca50bb04790687ef85265078f2d7d51"}, {"line": 21268, "relation": "association", "evidence": "Myeloperoxidase, a heme protein expressed by professional phagocytic cells, generates an array of oxidants which are proposed to contribute to tissue damage during inflammation.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"MeSHDisease": {"Inflammation": true}, "Cell": {"phagocyte": true}, "Subgraph": {"Myeloperoxidase subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}}, "source": 3, "target": 8, "key": "ef22a10d97034c1480d3b6e220a5e8072134a49c4ba0b57d0417280a337fd16ce954580fbb984b8cee6150f55f728476bd6e5dea32dec821f0e463dc3d4d44f5"}, {"line": 21297, "relation": "association", "evidence": "The increase in neuronal myeloperoxidase expression we observed in Alzheimer disease brains raises the possibility that the enzyme contributes to the oxidative stress implicated in the pathogenesis of the neurodegenerative disorder.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"Disease": {"Alzheimer's disease": true, "neurodegenerative disease": true}, "MeSHAnatomy": {"Brain": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 3, "target": 2, "key": "432d71f419b83296076ce64f51a1008c796a092c84d65dd65f6082eb6740da60212bbeae239d1b912396344bd9a61caa7935a2c9b12c320df344b5d6444c7dac"}, {"line": 23477, "relation": "increases", "evidence": "The increase in neuronal myeloperoxidase expression we observed in Alzheimer disease brains raises the possibility that the enzyme contributes to the oxidative stress implicated in the pathogenesis of the neurodegenerative disorder.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"Disease": {"Alzheimer's disease": true, "neurodegenerative disease": true}, "MeSHAnatomy": {"Brain": true, "Neurons": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 3, "target": 2, "key": "34e67cf02ee5da559971c403e16b0a264136c27249e4996c0b1af7d601c44b5869b59c39e693220d6b1150afe6cd5991e5923d94d659f07126ad5bdf4fc1e787"}, {"line": 23417, "relation": "increases", "evidence": "Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.", "citation": {"type": "PubMed", "reference": "19059911"}, "annotations": {"MeSHDisease": {"Memory Disorders": true, "Alzheimer Disease": true}, "MeSHAnatomy": {"Astrocytes": true}, "Species": {"10090": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 3, "target": 6, "key": "2829f38a46fe42a7decd78cace863d183de6a07418857f11f9eec4d517eacaf771ac2db63570dfc0de1125ecaa859167a5676c1c1741394a11a11ddbe8ec4c85"}, {"line": 23529, "relation": "association", "evidence": "However, the possible role of MPO and enzymatically inactive MPO (iMPO) as the choreographers of the destruction done by TNF-alpha and ROS is not generally recognized.", "citation": {"type": "PubMed", "reference": "18554520"}, "annotations": {"Subgraph": {"Myeloperoxidase subgraph": true, "Tumor necrosis factor subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 3, "target": 0, "key": "d37c84cffb8176fd2e28661f936eb3a3fdf981eee247beb1f1bec9efd41a93e7db948e135c28b36e3d3cbf717efc6be8acd0ed9edb3146be291f17f27cd90363"}, {"line": 23533, "relation": "association", "evidence": "However, the possible role of MPO and enzymatically inactive MPO (iMPO) as the choreographers of the destruction done by TNF-alpha and ROS is not generally recognized.", "citation": {"type": "PubMed", "reference": "18554520"}, "annotations": {"Subgraph": {"Myeloperoxidase subgraph": true, "Tumor necrosis factor subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 3, "target": 4, "key": "b1b84c2182cfd08548b4b39bc7283a51128f9c8aef5085f53f15ba26b08658dcf0015fc803c69a8ed70f60a8015885e0e69e5b418217989b68066b2c49548a59"}, {"line": 23529, "relation": "association", "evidence": "However, the possible role of MPO and enzymatically inactive MPO (iMPO) as the choreographers of the destruction done by TNF-alpha and ROS is not generally recognized.", "citation": {"type": "PubMed", "reference": "18554520"}, "annotations": {"Subgraph": {"Myeloperoxidase subgraph": true, "Tumor necrosis factor subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 0, "target": 3, "key": "b95be8f3a6e86418d965307f1eb1e3d025a84ef65f76b114b794340c8ef8f09f4821fa0d712599c702d14a5304bf5bb6688bd8a47e422815df3d226c60358a59"}, {"line": 23533, "relation": "association", "evidence": "However, the possible role of MPO and enzymatically inactive MPO (iMPO) as the choreographers of the destruction done by TNF-alpha and ROS is not generally recognized.", "citation": {"type": "PubMed", "reference": "18554520"}, "annotations": {"Subgraph": {"Myeloperoxidase subgraph": true, "Tumor necrosis factor subgraph": true, "Reactive oxygen species subgraph": true}, "Confidence": {"High": true}}, "source": 4, "target": 3, "key": "4da4b701a2e190b077d415b7fe07b9cdafdcf74d68dacb1b2421f31cd657ad20c28830cf54ba3fc5a28fb52109a677a03696b175898c3b047455fb816eaf0de1"}, {"line": 23478, "relation": "association", "evidence": "The increase in neuronal myeloperoxidase expression we observed in Alzheimer disease brains raises the possibility that the enzyme contributes to the oxidative stress implicated in the pathogenesis of the neurodegenerative disorder.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"Disease": {"Alzheimer's disease": true, "neurodegenerative disease": true}, "MeSHAnatomy": {"Brain": true, "Neurons": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 7, "target": 2, "key": "eec1bd92c287a9145c0788fb0ae01db5b79f0ac29d50ab71cffe18223c3f5158afbb9b5182316a579d97ef3190462cd0b19ac4afe9e578c8f303d5df296f6a40"}, {"line": 23478, "relation": "association", "evidence": "The increase in neuronal myeloperoxidase expression we observed in Alzheimer disease brains raises the possibility that the enzyme contributes to the oxidative stress implicated in the pathogenesis of the neurodegenerative disorder.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"Disease": {"Alzheimer's disease": true, "neurodegenerative disease": true}, "MeSHAnatomy": {"Brain": true, "Neurons": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 2, "target": 7, "key": "20a9cad5aa4f6a6e904dcf2ed065a4a948c77c6c0a13eefef915d62b97f4a446a9507ad24b7ba7ef42f9f832f1e17c1393325b42f760ec64b6abe701ee927d08"}, {"line": 21297, "relation": "association", "evidence": "The increase in neuronal myeloperoxidase expression we observed in Alzheimer disease brains raises the possibility that the enzyme contributes to the oxidative stress implicated in the pathogenesis of the neurodegenerative disorder.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"Disease": {"Alzheimer's disease": true, "neurodegenerative disease": true}, "MeSHAnatomy": {"Brain": true}, "Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"High": true}}, "source": 2, "target": 3, "key": "80c73bca1d479e4df4749729beb5adb47ac0defa26bfdeb4e7c22bf42f6cc0134561b31c542b58749706f1d611cba5f31ca2cc0c7a127002b744d33ffa4503c8"}, {"line": 21268, "relation": "association", "evidence": "Myeloperoxidase, a heme protein expressed by professional phagocytic cells, generates an array of oxidants which are proposed to contribute to tissue damage during inflammation.", "citation": {"type": "PubMed", "reference": "15255951"}, "annotations": {"MeSHDisease": {"Inflammation": true}, "Cell": {"phagocyte": true}, "Subgraph": {"Myeloperoxidase subgraph": true, "Inflammatory response subgraph": true}, "Confidence": {"High": true}}, "source": 8, "target": 3, "key": "0cf5fc2ad492ada8d513576e6406081500add1f826e6e74681d311cb03234c261b760bb4bd47766504d5164e6cbab6bef6dd06cf844e5eff833d127c9e8bf164"}, {"line": 29518, "relation": "decreases", "evidence": "Rivastigmine (1 mg/kg) also reduced myeloperoxidase activity and IL-6 by >60%, and the infiltration of CD11b expressing cells by 80%. These effects were accompanied by significantly greater ChE inhibition in cortex, brain stem, plasma and colon than that after 0.5 mg/kg.", "citation": {"type": "PubMed", "reference": "23469045"}, "annotations": {"Subgraph": {"Myeloperoxidase subgraph": true}, "Confidence": {"Medium": true}}, "object": {"modifier": "Activity"}, "source": 1, "target": 3, "key": "eef9184636d4db5b4f29dffb5c4669d1a09f6a5ec90a6d6f03c4cf9a549c4a169b8e5f70d26d7e30dd6b0477078cdf7c4d89afd8b95dbc7f7eb57f5bb066fc94"}]}